Proportion of heart failure patients age 18 and older with LVSD for whom beta-blocker therapy (i.e., bisoprolol, carvedilol, or sustained-release metoprolol succinate) is prescribed at discharge. For purposes of this measure, LVSD is defined as chart documentation of a left ventricular ejection fraction (LVEF) less than 40% or a narrative description of left ventricular systolic (LVS) function consistent with moderate or severe systolic dysfunction.
Patients who are prescribed bisoprolol, carvedilol, or sustained-release metoprolol succinate for LVSD at hospital discharge.
Denominator
1.15 Denominator
Heart failure patients with current or prior documentation of left ventricular ejection fraction (LVSD) < 40%.
Exclusions
Exclusions
Excluded Populations: • Patients who had a left ventricular assistive device (LVAD) or heart transplant procedure during hospital stay (ICD-10-PCS procedure code for LVAD and heart transplant as defined in Appendix A, Table 2.2) • Patients less than 18 years of age • Patients who have a Length of Stay greater than 120 days • Patients with Comfort Measures Only documented • Patients enrolled in a Clinical Trial • Patients discharged to another hospital • Patients who left against medical advice • Patients who expired • Patients discharged to home for hospice care • Patients discharged to a healthcare facility for hospice care • Patients with a documented Reason for No Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Succinate Prescribed for LVSD at Discharge
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Cardiovascular Fall Cycle 2018
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
The Joint Commission
Steward POC email
jalban@jointcommission.org
Steward Organization Copyright
This measure resides in the public domain and is not copyrighted
Public Comments